An intranasal influenza vaccine said to be extra successful than the injectable influenza vaccine. This concluded in the research on children between 6 months to 5 years of age. The research presented at the yearly conference of the Pediatric Academic Societies in San Francisco.
This is the biggest head-to-head influenza vaccine study yet conducted. The research was on nearly 8,500 children at 249 sites in 16 countries. With about half got the U.S. Food and Drug Administration (FDA) approved injectable vaccines. The other half got the nasal spray influenza vaccine. It was found out that the intranasal vaccine was appreciably extra efficient in protecting these children against influenza infection than the injectable one.
Read